These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14584953)

  • 1. CpG oligonucleotides with modified termini and nicked dumbbell structure show enhanced immunostimulatory activity.
    Narayanan S; Dalpke AH; Siegmund K; Heeg K; Richert C
    J Med Chem; 2003 Nov; 46(23):5031-44. PubMed ID: 14584953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z; Guo K; Schluesener HJ
    J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory CpG oligonucleotides form defined three-dimensional structures: results from an NMR study.
    He G; Patra A; Siegmund K; Peter M; Heeg K; Dalpke A; Richert C
    ChemMedChem; 2007 Apr; 2(4):549-60. PubMed ID: 17366653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
    Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
    J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity.
    Rattanakiat S; Nishikawa M; Funabashi H; Luo D; Takakura Y
    Biomaterials; 2009 Oct; 30(29):5701-6. PubMed ID: 19604576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of murine macrophage IL-12 production by natural and synthetic DNA.
    Pisetsky DS; Reich CF
    Clin Immunol; 2000 Sep; 96(3):198-204. PubMed ID: 10964537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides.
    Zhu FG; Reich CF; Pisetsky DS
    J Leukoc Biol; 2002 Apr; 71(4):686-94. PubMed ID: 11927656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA.
    Yu D; Kandimalla ER; Zhao Q; Bhagat L; Cong Y; Agrawal S
    Bioorg Med Chem; 2003 Feb; 11(3):459-64. PubMed ID: 12517441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.
    Tewary P; Sukumaran B; Saxena S; Madhubala R
    Vaccine; 2004 Aug; 22(23-24):3053-60. PubMed ID: 15297055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and immunostimulatory properties of CpG DNAs containing alkyl-linker substitutions: role of nucleosides in the flanking sequences.
    Yu D; Kandimalla ER; Cong Y; Tang J; Tang JY; Zhao Q; Agrawal S
    J Med Chem; 2002 Sep; 45(20):4540-8. PubMed ID: 12238933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.
    Bianco A; Hoebeke J; Godefroy S; Chaloin O; Pantarotto D; Briand JP; Muller S; Prato M; Partidos CD
    J Am Chem Soc; 2005 Jan; 127(1):58-9. PubMed ID: 15631447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dialkoxylphenyl compounds with oxime group on macrophage function and the proliferation of lymphocytes.
    Yoo ES; Son HJ; Park JS; Kim AR; Baik KU; Park MH; Cho JY
    J Pharm Pharmacol; 2004 Apr; 56(4):503-12. PubMed ID: 15099445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
    Jurk M; Kritzler A; Debelak H; Vollmer J; Krieg AM; Uhlmann E
    ChemMedChem; 2006 Sep; 1(9):1007-14. PubMed ID: 16952134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
    Chagnon F; Tanguay S; Ozdal OL; Guan M; Ozen ZZ; Ripeau JS; Chevrette M; Elhilali MM; Thompson-Snipes LA
    Clin Cancer Res; 2005 Feb; 11(3):1302-11. PubMed ID: 15709202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
    Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
    Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uniform small graphene oxide as an efficient cellular nanocarrier for immunostimulatory CpG oligonucleotides.
    Sun J; Chao J; Huang J; Yin M; Zhang H; Peng C; Zhong Z; Chen N
    ACS Appl Mater Interfaces; 2014 May; 6(10):7926-32. PubMed ID: 24712847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells.
    Theiner G; Rössner S; Dalpke A; Bode K; Berger T; Gessner A; Lutz MB
    Mol Immunol; 2008 Jan; 45(1):244-52. PubMed ID: 17599410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.